Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Koopman M"" wg kryterium: Wszystkie pola

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 6214
Tytuł:
Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response.
Autorzy:
Smabers LP; Department of Medical Oncology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
Wensink E; Department of Medical Oncology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
Verissimo CS; HUB Organoids B.V, Utrecht, The Netherlands.
Koedoot E; HUB Organoids B.V, Utrecht, The Netherlands.
Pitsa KC; HUB Organoids B.V, Utrecht, The Netherlands.
Huismans MA; Molecular Cancer Research, Center for Molecular Medicine, UMCU, Utrecht, The Netherlands.
Higuera Barón C; HUB Organoids B.V, Utrecht, The Netherlands.
Doorn M; HUB Organoids B.V, Utrecht, The Netherlands.
Valkenburg-van Iersel LB; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands.
Cirkel GA; Department of Medical Oncology, Meander Medical Center, Amersfoort, The Netherlands.
Brousali A; Utrecht Platform for Organoid Technology (UPORT), UMCU, Utrecht, The Netherlands.
Overmeer R; HUB Organoids B.V, Utrecht, The Netherlands.
Koopman M; Department of Medical Oncology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
Braat MN; Department of Radiology, UMCU, Utrecht, The Netherlands.
Penning de Vries B; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, UMCU, Utrecht, The Netherlands.
Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, UMCU, Utrecht, The Netherlands.
Vries RG; HUB Organoids B.V, Utrecht, The Netherlands.
Kranenburg O; Utrecht Platform for Organoid Technology (UPORT), UMCU, Utrecht, The Netherlands.; Laboratory of Translational Oncology, Division of Imaging and Cancer, UMCU, Utrecht, The Netherlands.
Boj SF; HUB Organoids B.V, Utrecht, The Netherlands. .
Roodhart JM; Department of Medical Oncology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Feb 27; Vol. 43 (1), pp. 61. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Colonic Neoplasms*/drug therapy
Humans ; Irinotecan/pharmacology ; Irinotecan/therapeutic use ; Oxaliplatin/pharmacology ; Oxaliplatin/therapeutic use ; Acetylcysteine/therapeutic use ; Precision Medicine ; Fluorouracil/pharmacology ; Fluorouracil/therapeutic use ; Organoids ; Antineoplastic Combined Chemotherapy Protocols/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Targeting Lifestyle Behavior to Improve Brain Health: User-Experiences of an Online Program for Individuals with Subjective Cognitive Decline
Autorzy:
Wesselman, Linda M. P.Aff1, Aff9
Schild, A. K.
Hooghiemstra, A. M.Aff1, Aff3
Meiberth, D.
Drijver, A. J.
Leeuwenstijn-Koopman, M. V.
Prins, N. D.
Brennan, S.
Scheltens, P.
Jessen, F.Aff2, Aff6
van der Flier, W. M.Aff1, Aff7
Sikkes, S. A. M.Aff1, Aff8
Pokaż więcej
Źródło:
The Journal of Prevention of Alzheimer's Disease. 7(3):184-194
Czasopismo naukowe
Szczegóły
Tytuł:
Industry-based development of effective new seabird mitigation devices in the southern Australian trawl fisheries
Autorzy:
Koopman, M
Boag, S
Tuck, GN
Hudson, R
Knuckey, I
Alderman, R
Pokaż więcej
Temat:
Zoology
QL1-991
Botany
QK1-989
Źródło:
Endangered Species Research, Vol 36, Pp 197-211 (2018)
Opis pliku:
electronic resource
Relacje:
https://www.int-res.com/abstracts/esr/v36/p197-211/; https://doaj.org/toc/1863-5407; https://doaj.org/toc/1613-4796
Dostęp URL:
https://doaj.org/article/fcead3ca826d49bc9dc9b9c1de14bef6  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands
Autorzy:
Kwakman, Johannes J. M.Aff1, Aff20
Vink, G.
Vestjens, J. H.
Beerepoot, L. V.
de Groot, J. W.
Jansen, R. L.
Opdam, F. L.
Boot, H.
Creemers, G. J.
van Rooijen, J. M.
Los, M.
Vulink, A. J. E.
Schut, H.
van Meerten, E.
Baars, A.
Hamberg, P.
Kapiteijn, E.
Sommeijer, D. W.Aff1, Aff18
Punt, C. J. A.
Koopman, M.
Pokaż więcej
Źródło:
International Journal of Clinical Oncology. 23(3):482-489
Czasopismo naukowe
Szczegóły
Tytuł:
Sint Hilaire du Harcouët.Officiële ontvangst in het stadhuis.Toespraak door burgemeester van Sint Hilaire, dr. D. Cuche. Op de voorste rij burgemeester van Zierikzee mr. F.Th. Dijckmeester; op de tweede rij v.l.n.r: Leen Koopman, M. Bij de Vaate, jkvr. Dijckmeester-de Brauw. Daarachter Arie Meerdink.SW 1349
Dostęp URL:
https://www.europeana.eu/item/2021642/Atlantispubliek_Default_aspx_detail_52768419?utm_source=api&utm_medium=api&utm_campaign=YuvuWBeCa  Link otwiera się w nowym oknie
Szczegóły
Tytuł:
Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing
Autorzy:
Vessies, D. C. L.
Greuter, M. J. E.
van Rooijen, K. L.
Linders, T. C.
Lanfermeijer, M.
Ramkisoensing, K. L.
Meijer, G. A.
Koopman, M.
Coupé, V. M. H.
Vink, G. R.Aff3, Aff5
Fijneman, R. J. A.
van den Broek, D.
Pokaż więcej
Źródło:
Scientific Reports. 10(1)
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database.
Autorzy:
Ou FS; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.
Ahn DH; Division of Medical Oncology, Mayo Clinic, Phoenix, AZ 85259, USA.
Dixon JG; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.
Grothey A; West Cancer Center, University of Tennessee, Memphis, TN 38104, USA.
Lou Y; Vertex Pharmaceuticals, Boston, MA 02210, USA.
Kasi PM; Division of Hematology and Oncology, University of Iowa, Iowa City, IA 52242, USA.
Hubbard JM; Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Van Cutsem E; Department of Gastroenterology/Digestive Oncology, University Hospitals Gasthuisberg Leuven and KU Leuven, 3000 Leuven, Belgium.
Saltz LB; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Schmoll HJ; Department of Internal Medicine, Clinic for Internal Medicine IV, Martin-Luther-University Halle/Saale, 06120 Halle, Germany.
Goldberg RM; West Virginia University Cancer Institute, West Virginia University, Morgantown, WV 26506, USA.
Venook AP; Department of Medicine, The University of California San Francisco, San Francisco, CA 94143, USA.
Hoff P; Department of Clinical Oncology, University of Sao Paulo, Sao Paulo 05508-010, Brazil.
Douillard JY; Department of Medical Oncology, University of Nantes Medical School, 44035 Nantes, France.
Hecht JR; Ronald Reagan UCLA Medical Center, Los Angeles, CA 90095, USA.
Hurwitz H; Duke Cancer Institute, Duke University, Durham, NC 27710, USA.
Punt CJA; Julius Center, University Medical Centre Utrecht, Utrecht University, 3584 CG Utrecht, The Netherlands.
Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Bokemeyer C; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Fuchs CS; Yale Cancer Center, New Haven, CT 06510, USA.
Diaz-Rubio E; Department of Oncology, Hospital Clínico San Carlos, 28040 Madrid, Spain.
Tebbutt NC; Sydney Medical School, University of Sydney, Sydney, NSW 2050, Australia.
Cremolini C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
Kabbinavar FF; Cardiff Oncology, San Diego, CA 92121, USA.
Bekaii-Saab T; Division of Medical Oncology, Mayo Clinic, Phoenix, AZ 85259, USA.
Chibaudel B; Department of Medical Oncology, Franco-British Institute, 92300 Levallois-Perret, France.
Yoshino T; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba 277-8577, Japan.
Zalcberg J; School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC 3004, Australia.
Adams RA; Centre for Trials Research, Cardiff University, Cardiff CF14 4YS, UK.; Velindre Cancer Center, Velindre NHS Trust, Cardiff CF14 2TL, UK.
de Gramont A; Department of Medical Oncology, Franco-British Institute, 92300 Levallois-Perret, France.
Shi Q; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Aug 15; Vol. 15 (16). Date of Electronic Publication: 2023 Aug 15.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognostic value of Lynch syndrome, BRAF , and RAS mutational status in dMMR/MSI-H metastatic colorectal cancer in a pooled analysis of Dutch and French cohorts.
Autorzy:
Zwart K; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
van der Baan FH; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Cohen R; Department of Medical Oncology, Équipe Instabilité des Microsatellites et Cancer, Équipe Labellisée par la Ligue Nationale Contre le Cancer et SIRIC CURAMUS, Centre de recherche Saint Antoine, Hôpital Saint-Antoine, AP-HP, and INSERM UMRS 938, Sorbonne Université, Paris, France.
Aparicio T; Gastroenterology Department, Saint Louis Hospital, AP-HP, University of Paris, Paris, France.; Gastroenterology Department, Avicenne Hospital, Bobigny, France.
de la Fouchardiére C; Medical Oncology Department, Léon Bérard Center, Lyon, France.
Lecomte T; Department of Hepato-Gastroenterology and Digestive Oncology, Tours University Hospital and INSERM UMR 1069 N2C, University of Tours, Tours, France.
Punt CJA; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Sefrioui D; Digestive Oncology Unit, Department of Hepatogastroenterology, Rouen University Hospital, IRON Group and INSERM U1245, University of Normandy, Rouen, France.
Verheijden RJ; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Vink GR; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Wensink GE; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Zaanan A; Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, Assistance publique-Hôpitaux de Paris, SIRIC CARPEM, University Paris Cité, Paris, France.
Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Tougeron D; Hepato-Gastroenterology Department, Poitiers University Hospital, University of Poitiers, Poitiers, France.
Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Aug; Vol. 12 (15), pp. 15841-15853. Date of Electronic Publication: 2023 Jun 16.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Colorectal Neoplasms, Hereditary Nonpolyposis*/genetics
Colorectal Neoplasms*/pathology
Colonic Neoplasms*
Rectal Neoplasms*
Humans ; Male ; Middle Aged ; Female ; Prognosis ; Proto-Oncogene Proteins B-raf/genetics ; DNA Mismatch Repair/genetics ; Mutation ; Observational Studies as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 6214

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies